Comparative diagnostic performance of plasma microbial cell-free DNA sequencing versus amplicon-based blood next-generation sequencing in suspected bloodstream or endovascular infection: a single-center study

Read full text Summarise with VIRAT
Authors: Mayar Al Mohajer, Todd Michael Lasco
Cited by: 0
References: 6

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

We compared plasma microbial cell-free DNA sequencing (mcfDNAseq) with an amplicon-based blood next-generation sequencing (NGS) assay for 10 patients with suspected bloodstream or endovascular infection. Plasma testing detected pathogens in eight (seven clinically meaningful), whereas amplicon testing was negative in all. Plasma mcfDNAseq provided higher test yield and overall sensitivity.

Fields of Study & Subjects

Bacterial Identification and Susceptibility Testing Genomics and Phylogenetic Studies Infective Endocarditis Diagnosis and Management

Publication details

Journal / source
Antimicrobial Stewardship & Healthcare Epidemiology
Volume
6
Issue
1
Pages
e69–e69
Publication date
27 March 2026
Language
EN